Combination therapy targeting both cancer stem-like cells and bulk tumor cells for improved efficacy of breast cancer treatment
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combination therapy targeting both cancer stem-like cells and bulk tumor cells for improved efficacy of breast cancer treatment
Authors
Keywords
-
Journal
CANCER BIOLOGY & THERAPY
Volume 17, Issue 6, Pages 698-707
Publisher
Informa UK Limited
Online
2016-06-04
DOI
10.1080/15384047.2016.1190488
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Salinomycin treatment reduces metastatic tumor burden by hampering cancer cell migration
- (2014) Florian Kopp et al. Molecular Cancer
- Salinomycin as a Drug for Targeting Human Cancer Stem Cells
- (2012) Cord Naujokat et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles
- (2011) Yang Zhang et al. BIOMATERIALS
- Salinomycin inhibits osteosarcoma by targeting its tumor stem cells
- (2011) Qing-Lian Tang et al. CANCER LETTERS
- Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype
- (2011) S. Ricardo et al. JOURNAL OF CLINICAL PATHOLOGY
- Wnt/β-catenin signaling regulates cancer stem cells in lung cancer A549 cells
- (2010) Ying Teng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor
- (2010) Roberta Riccioni et al. BLOOD CELLS MOLECULES AND DISEASES
- Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein
- (2010) Ju-Hwa Kim et al. BRITISH JOURNAL OF PHARMACOLOGY
- Synergistic Activity of Sorafenib and Sulforaphane Abolishes Pancreatic Cancer Stem Cell Characteristics
- (2010) Vanessa Rausch et al. CANCER RESEARCH
- Heterogeneity for Stem Cell-Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer
- (2010) S. Y. Park et al. CLINICAL CANCER RESEARCH
- Kitlow Stem Cells Cause Resistance to Kit/Platelet-Derived Growth Factor α Inhibitors in Murine Gastrointestinal Stromal Tumors
- (2010) Michael R. Bardsley et al. GASTROENTEROLOGY
- Targeting breast cancer stem cells
- (2010) Sean P. McDermott et al. Molecular Oncology
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
- (2009) Piyush B. Gupta et al. CELL
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
- (2009) C. J. Creighton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
- (2008) X. Li et al. JNCI-Journal of the National Cancer Institute
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started